1612P Impact of FANCA, ATM, CDK12 alterations on survival in metastatic castration-resistant prostate cancer (mCRPC)
Lorente, D., Herrera Imbroda, B., Jambrina, A., Tello, D., Romero Laorden, N., Lopez Casas, P., Balongo, M., Ovejero, M., Almalé, L., Vidal Cassinello, N., Mendez Vidal, M.J., Capone, C., Vanden Broecke, A.M., Trevisan, M., Van Sanden, S., Jürgens, A., Gonzalez Billalabeitia, E., Olmos, D., Castro, E.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
147P Activity of single-agent PD-1/PD-L1 inhibitors in 1st-line (1L) “platinum-ineligible” patients (pts) with metastatic urothelial cancer (mUC) in real-life clinical practice
Molina Cerrillo, J., Ortego, I., Pinto Marin, A., Alonso Gordoa, T., Puente, J., Arranz Arija, J.A., Lopez Criado, M.P., Gonzalez Morales, A., Vidal Cassinello, N., Castellano Gauna, D.E., Sevillano Fernandez, E., Garcia Donas, J., Grande Pulido, E.
Published in Annals of oncology (01.11.2022)
Published in Annals of oncology (01.11.2022)
Get full text
Journal Article
87P Clinical features and genetic profile of MDM2-altered solid tumors
Tejerina-Peces, J., Bartolomé Arcilla, J., De La Hoya, M., Garre, P., Paz Cabezas, M., López de Sá, A., Cabezas-Camarero, S., García Paredes, B., Vidal Cassinello, N., Aguado, C., Marquina Ospina, G., Fernandez-Hinojal, G., Orta, A., Ortega, L., Ocana Fernandez, A., Pérez Segura, P., Manzano Fernández, A.
Published in ESMO open (01.03.2023)
Published in ESMO open (01.03.2023)
Get full text
Journal Article